DIC Corporation (TOKYO: 4631) has for some time been exploring the possibility of an alliance with Indias Jindal Poly Films Limited, one of the worlds largest manufacturers of biaxially oriented polypropylene (BOPP) film, with the aim of helping to foster a market for functional cast polypropylene (CPP) film in India. Today, DIC announced that the two companies have reached a consensus to collaborate in this area.
India, like other countries, is experiencing a greater need for products with performance features that respond better to environmental concerns and sanitation issues. In the food packaging field, demand is increasing for films with performance features that meet such needs. Of particular note, demand for functional CPP film, which contributes to the realization of reducing plastics, mono-material packaging, is expected to expand in the future.
Anticipating growth in the Indian market for CPP film, Jindal Poly Films entered this business in 2018, at which time it also approached DIC to propose collaboration. Having determined that working with Jindal Poly Films would be an important first step in nurturing demand in the promising Indian market, DIC explored the proposal in detail.
Collaborative initiatives in the following three spheres are under consideration by the two companies, with concrete activities expected to commence within fiscal year 2021 at the earliest:
- Entering into a technology licensing agreement whereby DIC would extend packaging technologies to Jindal Poly Films;
- Developing and mass-producing functional CPP film using DIC technologies at Jindal Poly Films plant in India; and
- Conducting joint sales of functional CPP film manufactured by Jindal Poly Films in India with a view to establishing a joint venture.
Through this business, DIC has sought to provide value to society through the improvement of environmental performance, i.e., by making films thinner to reduce plastic use, and enhancing performance features such as easy peel, which makes packaging easier to open.
Amid growing sustainability-related needs, DIC aims to expand its films business by capitalizing on this collaboration with Jindal Poly Films to introduce advanced technologies cultivated in Japan to the Indian market, which is expected to see significant growth going forward.
Corporate Communications Dept.
Launch of $2.65 billion Green Bond Offering
LUXEMBOURG, Feb. 24, 2021 /PRNewswire/ — Ardagh Group (“Ardagh”) (NYSE:ARD) announces that Ardagh Metal Packaging S.A. (“AMP” or the “Company”) has today, through its wholly-owned subsidiaries, Ardagh Metal Packaging Finance plc and Ardagh Metal Packaging Finance USA LLC, launched a bond financing of approximately $2.65 billion equivalent, through the issue of (i) $600 million US Dollar Senior Secured Notes due 2028, (ii) $550 million equivalent Euro Senior Secured Notes due 2028 (iii) $1,000 million Senior Notes due 2029 and (iv) $500 million equivalent Euro Senior Notes due 2029, (collectively the “Notes”).
The offering follows Ardagh's announcement on February 23, 2021 of the proposed combination of its metal packaging business with Gores Holdings V Inc, (NASDAQ:GRSV, GRSVU and GRSVW), under which Gores Holdings V will combine, subject to a shareholder vote, with Ardagh's beverage can business, that will be held by AMP. AMP intends to apply to list its shares on the New York Stock Exchange, under the new ticker symbol “AMBP”.
AMP is a leading global supplier of sustainable beverage cans and is the second-largest producer in Europe and the third-largest in North America and Brazil. The Company believes that strong demand in traditional and new beverage categories, coupled with environmentally conscious end consumers, are driving an inflection point in beverage can demand and that it is well positioned to capitalize on these multifaceted growth opportunities. AMP has a highly attractive sustainability profile, and the Notes will be issued in accordance with Ardagh's Green Financing framework.
Gross proceeds of the Notes will be held in escrow until the entities currently conducting the metal packaging business within Ardagh transfer to become wholly-owned subsidiaries of AMP, and AMP and its subsidiaries will be released from their obligations under existing Ardagh notes. Proceeds, net of expenses, will then be used to pay $2,315 million equivalent to Ardagh in part consideration for this transfer.
About Ardagh Group
Ardagh is a global supplier of infinitely-recyclable metal and glass packaging for the world's leading brands. Ardagh operates 56 metal and glass production facilities in 12 countries, employing more than 16,000 people with sales of approximately $7 billion.
About Ardagh Metal Packaging
AMP will hold Ardagh's metal packaging business, which is a leading supplier of beverage cans globally, with a particular focus on The Americas and Europe. Ardagh's metal packaging business operates 23 production facilities in Europe and the Americas, employs approximately 4,900 people and recorded revenues of $3.5 billion in 2020.
The offering of the Notes will be made pursuant to an exemption under the Prospectus Regulation, as implemented in Member States of the European Economic Area, from the requirement to produce a prospectus for offers of securities. This announcement does not constitute an advertisement for the purposes of the Prospectus Regulation.
The offering of the Notes will be made pursuant to an exemption under the UK Financial Services and Markets Act 2000 and the UK Prospectus Regulation from the requirement to produce a prospectus for offers of securities. This announcement does not constitute an advertisement for the purposes of the UK Prospectus Regulation.
The Notes have not been registered under the U.S. Securities Act of 1933, as amended, or any U.S. State security laws. Accordingly, the Notes are being offered and sold in the United States only to qualified institutional buyers in accordance with Rule 144A under the U.S. Securities Act of 1933 and outside the United States in accordance with Regulation S under the U.S. Securities Act of 1933. This announcement does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor will there be any sale of securities referred to in this announcement, in any jurisdiction, including the United States, in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. Securities may not be offered or sold in the United States absent registration under the U.S. Securities Act of 1933, or an exemption from registration.
MiFID II professionals/ECPs-only/No PRIIPs KID – Manufacturer target market (MIFID II product governance) is eligible counterparties and professional clients only (all distribution channels). No PRIIPs key information document (KID) has been prepared as not available to retail in EEA.
UK MiFIR professionals/COBS ECPs-only/No UK PRIIPs KID – Manufacturer target market (UK MiFIR product governance) is eligible counterparties and professional clients only (all distribution channels). No UK PRIIPs key information document (KID) has been prepared as not available to retail in UK.
This press release contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014. The person responsible for the release of this information on behalf of Ardagh Metal Packaging S.A., Ardagh Metal Packaging Finance plc and Ardagh Metal Packaging Finance USA LLC is John Sheehan.
The documentation detailing the investment or investment activity to which this press release relates has not been approved by an authorized person in the United Kingdom and is for distribution only to persons who (i) have professional experience in matters relating to investments falling within Article 19(5) of the UK Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the “Financial Promotion Order”), (ii) are persons falling within Articles 49(2)(a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Promotion Order, (iii) are outside the United Kingdom or (iv) are persons to whom an invitation or inducement to engage in investment activity within the meaning of Section 21 of the UK Financial Services and Markets Act 2000 in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as “relevant persons”). The documentation detailing the investment or investment activity is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this press release relates is available only to relevant persons and will be engaged in only with relevant persons.
View original content to download multimedia:http://www.prnewswire.com/news-releases/launch-of-2-65-billion-green-bond-offering-301235083.html
SOURCE Ardagh Group S.A.
Coleman Institute Withdrawal Management Now Covered by BCBS of MA
WELLESLEY, Mass., Feb. 24, 2021 /PRNewswire-PRWeb/ — The Coleman Institute for Addiction Medicine, specialists in addiction treatment services for over 20 years, announced today the expansion of its in-network coverage with Blue Cross Blue Shield of Massachusetts at its outpatient detoxification office in Wellesley, MA. Conveniently located in a suburb less than 20 miles west of Boston, the Coleman Institute is one of the only licensed Outpatient Detoxification providers in the New England region. The Coleman Institute is a division of BayMark Health Services. Led by National Medical Director Dr. Peter Coleman, creator of the Coleman Method, and Medical Director Dr. Deborah Reich, Coleman's addiction professionals are experts in their field.
The Coleman Institute team offers a broad range of treatment services at its Wellesley location, including detoxification from alcohol and opioids. Medically-supervised detox is supported by six months of ongoing naltrexone therapy and case management services, including individualized aftercare planning with patients. The Coleman Method for accelerated outpatient detox typically takes 3-9 days to safely detox patients, getting them back to their lives with minimal disruption.
The Boston area office is now in-network with Tufts Health Plans, Humana, and many Blue Cross Blue Shield plans nationwide. The team also explores out-of-network (OON) options for potential patients and expects to expand coverage with other insurers in the near future.
Dr. Peter Coleman, National Medical Director of the Coleman Institute for Addiction Medicine, shared, “Our goal is to bring evidence-based treatment to those in need. Massachusetts continues to see some of the highest rates of substance use disorder in the country. In particular, during this time of COVID-19, people are dealing with increased levels of stress and anxiety. The need for access to treatment for both Alcohol Use Disorder (AUD) and Opioid Use Disorder (OUD) is escalating. Our proven methods allow us to bring hope and freedom to those struggling with dependence. In addition, ongoing naltrexone therapy and case management support is a critical part of providing our patients with the best opportunity to experience long-term recovery.”
There are multiple evidence-based approaches for helping people struggling with addiction, and the Coleman Method focuses on getting patients off of addictive substances and guiding them into long-term recovery. The Coleman Institute's withdrawal management services help patients transition onto Medication-Assisted Treatment using the non-addictive opioid blocker Naltrexone.
For more information on The Coleman Institute for Addiction Medicine, or to make an appointment, visit: http://www.TheColemanInstitute.com.
About the Coleman Method:
The Coleman Institute for Addiction Medicine, a division of BayMark Health Services, provides detox services using the Coleman Method. Beginning in 1998, Dr. Peter Coleman developed and refined a unique, customizable approach for helping patients overcome their physical dependency on opiates or alcohol and then accessing the long-term support resources needed to maintain their recovery.
The Coleman Method for accelerated opioid detox has helped thousands of patients detoxify and recover from the effects of heroin use and other opioids such as OxyContin®, Percocet® and fentanyl. It enables 98% of patients to successfully complete their detox and begin Naltrexone therapy.
Besides Wellesley, the Coleman Method is available at 13 offices nationwide. Dr. Coleman has trained the physicians in these practices to provide similar detox services.
Andrew Blake, The Coleman Institute, 781.622.9590, [email protected]
SOURCE The Coleman Institute
USHG Acquisition Corp. Announces Pricing of $250 Million Initial Public Offering
NEW YORK, Feb. 24, 2021 /PRNewswire/ — USHG Acquisition Corp. (the “Company”) announced today the pricing of its initial public offering of 25,000,000 units at a price of $10.00 per unit. The units will be listed on the New York Stock Exchange (“NYSE”) and will trade under the ticker symbol “HUGSU” beginning on February 25, 2021. Each unit issued in the offering consists of one share of the Company's Class A common stock and one-third of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one share of Class A common stock at an exercise price of $11.50 per share. After the securities comprising the units begin separate trading, the shares of Class A common stock and warrants are expected to be listed on NYSE under the symbols “HUGS” and “HUGSW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The offering is expected to close on March 1, 2021, subject to customary closing conditions.
Goldman Sachs & Co. LLC and Piper Sandler & Co. are acting as joint book-running managers for the offering. The Company has granted the underwriters a 45-day option to purchase up to an additional 3,750,000 units at the initial public offering price to cover over-allotments, if any.
The offering is being made only by means of a prospectus. Copies of the prospectus may be obtained, when available, from Goldman Sachs & Co. LLC, Attn: Prospectus Department, 200 West Street, New York, New York 10282-2198, Telephone: 1-866-471-2526, Email: [email protected]; or Piper Sandler & Co., Attn: Prospectus Department, 345 Park Avenue, New York, New York 10154, Telephone: 800-747-3924, Email: [email protected].
A registration statement relating to the securities was declared effective by the Securities and Exchange Commission (the “SEC”) on February 24, 2021. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About USHG Acquisition Corp.
USHG Acquisition Corp. is a blank check company sponsored by an affiliate of Union Square Hospitality Group, LLC and formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. USHG Acquisition Corp. intends to focus its search for business combination targets on culture-driven businesses across a range of industries, including, but not limited to, technology, e-Commerce, food and beverage, health and retail and consumer goods, although it may pursue an acquisition in any business industry or sector.
This press release contains statements that constitute “forward-looking statements,” including with respect to the Company's initial public offering and the anticipated use of the net proceeds. No assurance can be given that the offering will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement and prospectus for the offering filed with the SEC. Copies are available on the SEC's website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Email: [email protected]
View original content to download multimedia:http://www.prnewswire.com/news-releases/ushg-acquisition-corp-announces-pricing-of-250-million-initial-public-offering-301234685.html
SOURCE USHG Acquisition Corp.
VivoPower International PLC Reports Financial Results For The Six Months Ended December 31, 2020 and Landmark Global Battery Partnership with Tottenham Hotspur
Revenue, GP and EBITDA decline due to strict COVID-19 lockdowns in Australia Strategic pivot to enter commercial electric vehicle (EV)...
Solar Capital Partners Rebrands to SLR Capital Partners
NEW YORK, Feb. 24, 2021 /PRNewswire/ — Solar Capital Partners, LLC, a leading commercial finance platform with expertise across cash...
Farmer Mac Appoints Eric T. McKissack to Board of Directors
WASHINGTON, Feb. 24, 2021 /PRNewswire/ — The Federal Agricultural Mortgage Corporation (Farmer Mac; NYSE: AGM and AGM.A), the nation's secondary market...
AIFA Invites Demotech to Participate in March 2021 Annual Conference
COLUMBUS, Ohio, Feb. 24, 2021 /PRNewswire/ — Demotech, Inc. has been invited to be part of the Rating Agency panel...
The Valens Company Reports Financial Results for the Fourth Quarter and Fiscal Year Ended November 30, 2020
Strategic transformation from industry-leading extractor to largest third-party cannabis product manufacturer in Canada driving 292% Q4 2020 provincial sales growth...
New Development Fuels Net Lease Auto Sector
WILMETTE, Ill., Feb. 24, 2021 /PRNewswire-PRWeb/ — The Boulder Group announced the release of its Net Lease Auto Report today....
USHG Acquisition Corp. Announces Pricing of $250 Million Initial Public Offering
NEW YORK, Feb. 24, 2021 /PRNewswire/ — USHG Acquisition Corp. (the “Company”) announced today the pricing of its initial public offering...
Coleman Institute Withdrawal Management Now Covered by BCBS of MA
WELLESLEY, Mass., Feb. 24, 2021 /PRNewswire-PRWeb/ — The Coleman Institute for Addiction Medicine, specialists in addiction treatment services for over...
Launch of $2.65 billion Green Bond Offering
LUXEMBOURG, Feb. 24, 2021 /PRNewswire/ — Ardagh Group (“Ardagh”) (NYSE:ARD) announces that Ardagh Metal Packaging S.A. (“AMP” or the “Company”)...
Grupo Elektra Announces Revenues Of Ps.33,663 Million And EBITDA Of Ps.4,125 Million In 4Q20
MEXICO CITY, Feb. 24, 2021 /PRNewswire/ — Grupo Elektra, S.A.B. de C.V. (BMV: ELEKTRA*; Latibex: XEKT), Latin America's leading specialty...